Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
This collaboration is set to connect Abbott's CGM sensor with Medtronic's AID algorithms, allowing for automatic insulin ...
Elsewhere in diabetes, Medtronic received FDA clearance ... primarily focus on the global manufacturing of sensors for its continuous glucose monitoring (CGM) devices. "CeQur raises $120m to ...